Nuvation Bio annual revenue
2022
2023
2024
2025
Nuvation Bio reported $62.9M in revenue for fiscal 2025, an increase of 698.96% from the previous fiscal year.
View full Nuvation Bio company overview| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $62.9M | $55.0M | +698.96% |
| 2024 | 2024-12-31 | $7.9M | $7.9M | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | — | — |
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $31.7M | $26.9M | +555.64% |
| Q1 2026 | 2026-03-31 | $83.2M | $80.1M | +2598.70% |
| Q4 2025 | 2025-12-31 | $41.9M | $36.2M | +633.06% |
| Q3 2025 | 2025-09-30 | $13.1M | $12.4M | +1704.68% |
| Q2 2025 | 2025-06-30 | $4.8M | $3.4M | +236.79% |
| Q1 2025 | 2025-03-31 | $3.1M | $3.1M | — |
| Q4 2024 | 2024-12-31 | $5.7M | — | — |
| Q3 2024 | 2024-09-30 | $727,000 | $727,000 | — |
| Q2 2024 | 2024-06-30 | $1.4M | $1.4M | — |
| Q1 2024 | 2024-03-31 | $0 | — | — |
| Q3 2023 | 2023-09-30 | $0 | — | — |
| Q2 2023 | 2023-06-30 | $0 | — | — |
Nuvation Bio's latest reported quarter, Q2 2026, generated $31.7M in revenue, an increase of 555.64% year over year.
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Nuvation Bio source filings ↗